Heme oxygenase-1 signaling and redox homeostasis in physiopathological conditions
V Consoli, V Sorrenti, S Grosso, L Vanella - Biomolecules, 2021 - mdpi.com
Heme-oxygenase is the enzyme responsible for degradation of endogenous iron
protoporphyirin heme; it catalyzes the reaction's rate-limiting step, resulting in the release of …
protoporphyirin heme; it catalyzes the reaction's rate-limiting step, resulting in the release of …
The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk
M Femlak, A Gluba-Brzózka… - Lipids in health and …, 2017 - Springer
Background Diabetes mellitus (DM) is a major public health problem which prevalence is
constantly raising, particularly in low-and middle-income countries. Both diabetes mellitus …
constantly raising, particularly in low-and middle-income countries. Both diabetes mellitus …
Hyperglycemia and glycation in diabetic complications
A Negre-Salvayre, R Salvayre, N Augé… - Antioxidants & redox …, 2009 - liebertpub.com
Diabetes mellitus is a multifactorial disease, classically influenced by genetic determinants
of individual susceptibility and by environmental accelerating factors, such as lifestyle. It is …
of individual susceptibility and by environmental accelerating factors, such as lifestyle. It is …
Apolipoprotein AI (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer
F Su, KR Kozak, S Imaizumi, F Gao… - Proceedings of the …, 2010 - National Acad Sciences
We examined whether reduced levels of Apolipoprotein AI (apoA-I) in ovarian cancer
patients are causal in ovarian cancer in a mouse model. Mice expressing a human apoA-I …
patients are causal in ovarian cancer in a mouse model. Mice expressing a human apoA-I …
High density lipoprotein: it's not just about lipid transport anymore
Plasma levels of high density lipoprotein cholesterol (HDL-C) have long been associated
with protection against cardiovascular disease (CVD) in large populations. However, HDL-C …
with protection against cardiovascular disease (CVD) in large populations. However, HDL-C …
Heme as a target for therapeutic interventions
S Immenschuh, V Vijayan, S Janciauskiene… - Frontiers in …, 2017 - frontiersin.org
Heme is a complex of iron and the tetrapyrrole protoporphyrin IX with essential functions in
aerobic organisms. Heme is the prosthetic group of hemoproteins such as hemoglobin and …
aerobic organisms. Heme is the prosthetic group of hemoproteins such as hemoglobin and …
Translational significance of heme oxygenase in obesity and metabolic syndrome
NG Abraham, JM Junge, GS Drummond - Trends in pharmacological …, 2016 - cell.com
The global epidemic of obesity continues unabated with sequelae of diabetes and metabolic
syndrome. This review reflects the dramatic increase in research on the role of increased …
syndrome. This review reflects the dramatic increase in research on the role of increased …
ApoA-I and diabetes
TW King, BJ Cochran, KA Rye - Arteriosclerosis, Thrombosis, and …, 2023 - Am Heart Assoc
ApoA-I—the main apolipoprotein constituent of the HDL (high-density lipoprotein) fraction of
human plasma—is of therapeutic interest because it has several cardioprotective functions …
human plasma—is of therapeutic interest because it has several cardioprotective functions …
Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications
JA McClung, L Levy, V Garcia, DE Stec… - Pharmacology & …, 2022 - Elsevier
Obesity-mediated metabolic syndrome remains the leading cause of death worldwide.
Among many potential targets for pharmacological intervention, a promising strategy …
Among many potential targets for pharmacological intervention, a promising strategy …